[1] M. E. Arroliga and L. Pien, “Penicillin Allergy: Consider Trying Penicillin Again,” Cleveland Clinic Journal of Medicine, Vol. 70, No. 4, 2003, pp. 313-314.
http://dx.doi.org/10.3949/ccjm.70.4.313
[2] C. Walsh, “Molecular Mechanisms That Confer Antibacterial Drug Resistance,” Nature, Vol. 406, No. 6797, 2000, pp. 775-781. http://dx.doi.org/10.1038/35021219
[3] A. Ashnagar and N. G. Naseri, “Analysis of Three Penicillin Antibiotics (Ampicillin, Amoxicillin and Cloxacillin) of Several Iranian Pharmaceutical Companies by HPLC,” Journal of Chemistry, Vol. 4, No. 4, 2007, pp. 536-545.
[4] A. Sullivan, C. Edlund and C. E. Nord, “Effect of Antimicrobial Agents on the Ecological Balance of Human Microflora,” The Lancet Infectious Diseases, Vol. 1, No. 2, 2001, pp. 101-114.
http://dx.doi.org/10.1016/S1473-3099(01)00066-4
[5] C. M. Kaye, A. Allen, S. Perry, M. McDonagh, M. Davy, K. Storm, N. Bird and O. Dewit, “The Clinical Pharmacokinetics of a New Pharmacokinetically Enhanced Formulation of Amoxicillin/Clavulanate,” Clinical Therapeutics, Vol. 23, No. 4, 2001, pp. 578-584.
http://dx.doi.org/10.1016/S0149-2918(01)80061-8
[6] S. M. Drawz and R. A. Bonomo, “Three Decades of βLactamase Inhibitors,” Clinical Microbiology Reviews, Vol. 23, No. 1, 2010, pp. 160-201.
http://dx.doi.org/10.1128/CMR.00037-09
[7] M. Coll, J. Frau, B. Vilanova, J. Donoso, F. Munoz and F. G. Blanco, “Theoretical Study of the Alkaline Hydrolysis of a Bicyclic Aza-β-Lactam,” The Journal of Physical Chemistry B, Vol. 104, No. 47, 2000, pp. 11389-11394.
http://dx.doi.org/10.1021/jp001989e
[8] World Health Organisation (WHO), “Quality Assurance of Pharmaceuticals: A Compendium of Guidelines and Related Materials,” Vol. 2, Geneva, 2004.
[9] S. K. Opuni, “Alert: Osons Chemists, Roxin Ghana Import Fake Medicines from Ghana,” My Joy Online, 2013.
http://www.modernghana.com/news/445411/1/alert-osons-chemists-roxin-ghana-import-fake-medic.html
[10] S. Ayim, “List of Hospitals and Pharmacies in the Central Region of Ghana as recorded by the Regional Health Directorate,” Personal Interview, 2012.
[11] World Health Organisation (WHO), “The International Pharmacopoeia,” 4th Edition, 2nd Supplement, Geneva, 2008.
[12] Clinical and Laboratory Standards Institute, “Performance Standards for Antimicrobial Disk Susceptibility Test; Approved Standard,” CLSI Document M02-A10, 10th ed. 2009.
[13] British Pharmacopoeia Commission, “British Pharmacopoeia 2013,” Renouf Publishing Company Limited, UK, 2013.
[14] S. Sengaloundeth, M. D Green, F. M. Fernández, Ot. Manolin, K. Phommavong, V. Insixiengmay, C. Y. Hampton, L. Nyadong, D. C. Mildenhall, D. Hostetler, L. Khounsaknalath, L. Vongsack, S. Phompida, V. Vanisaveth, L. Syhakhang and P. N. Newton, “A Stratified Random Survey of the Proportion of Poor Quality Oral Artesunate Sold at Medicine Outlets in the Lao PDR—Implications for Therapeutic Failure and Drug Resistance,” Malaria Journal, Vol. 8, 2009, p. 172.
http://dx.doi.org/10.1186/1475-2875-8-172
[15] P. N. Newton, M. D. Green, D. C. Mildenhall, A. Plancon, H. Nettey, L. Nyadong, D. M. Hostetler, I. Swamidoss, G. A. Harris, K. Powell, A. E. Timmermans, A. A. Amin, S. K. Opuni, S. Barbereau, C. Faurant, R. C. W. Soong, K. Faure, J. Thevanayagam, P. Fernandes, H. Kaur, B. Angus, K. Stepniewska, P. J. Guerin and F. M. Fernández, “Poor Quality Vital Anti-Malarials in Africa—An Urgent Neglected Public Health Priority,” Malaria Journal, Vol. 10, 2011, p. 352.
http://dx.doi.org/10.1186/1475-2875-10-352
[16] E. A. Nyarko and H. Nettey, “Quality Assessment of Artemether/Lumefantrine Tablets Sampled from Pharmacies in Accra, Using the MVHimagePCv8.exe Color Software,” Pharmacology & Pharmacy, Vol. 4, 2013, pp. 567-572. http://dx.doi.org/10.4236/pp.2013.48081
[17] J. Feng, X. Zhana, S. Qiaob, C. Wub and L. Xiaob, “A Mathematical Model for Calculating the Shelf Life of Ascorbic Acid Solution under Given Conditions,” Drug Development and Industrial Pharmacy, Vol. 38, No. 3, 2012, pp. 264-270.
http://dx.doi.org/10.3109/03639045.2011.598537
[18] D. Q. Craig, “The Mechanisms of Drug Release from Solid Dispersions in Water-Soluble Polymers,” International Journal of Pharmaceutics, Vol. 231, No. 2, 2002, pp. 131-144.
http://dx.doi.org/10.1016/S0378-5173(01)00891-2
[19] S. A. Qureshi and J. Shabnam, “Cause of High Variability in Drug Dissolution Testing and Its Impact on Setting Tolerances,” European Journal of Pharmaceutical Sciences, Vol. 12, No. 3, 2001, pp. 271-276.
http://dx.doi.org/10.1016/S0928-0987(00)00174-3